Unknown

Dataset Information

0

One-year outcomes of conventional and accelerated collagen crosslinking in progressive keratoconus.


ABSTRACT: We compared one-year outcomes of conventional (3 mW/cm(2), 365-nm ultraviolet-A light, 30 minutes) and accelerated (18 mW/cm(2), 365-nm ultraviolet-A light, 5 minutes) collagen crosslinking (CXL) in patients with progressive keratoconus. Main outcome measures were change in keratometry, uncorrected visual acuity (UCVA), and best-corrected visual acuity (BCVA). Nineteen patients in each group completed 1-year follow-up. Preoperatively, there were no inter-group differences for age, keratometry, corneal thickness, and spherical equivalent (p > 0.127). One year postoperatively, maximum and minimum keratometry were flattened by 1.6 diopters (p < 0.023) and 2 diopters (p < 0.047) respectively after conventional CXL, and, 0.47 diopters (p = 0.471) and 0.19 diopters (p = 0.120) respectively after accelerated CXL. Association analysis showed significant negative association between baseline maximum keratometry and change in maximum keratometry after accelerated CXL (p = 0.002) but not after conventional CXL (p = 0.110). Corneal thickness was reduced significantly in both groups (p = 0.017). An improvement in UCVA (p < 0.001) and BCVA (p < 0.022) was noted in both groups along with a reduction in spherical equivalent postoperatively (p < 0.026). There were no inter-group differences for any of the parameters postoperatively (p > 0.184). Although no statistically significant differences were observed between both treatment modalities, a more effective topographic flattening was observed with conventional CXL as compared to accelerated CXL in this study.

SUBMITTER: Chow VW 

PROVIDER: S-EPMC4585888 | biostudies-other | 2015

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC4645452 | biostudies-literature
| S-EPMC5633701 | biostudies-literature
| S-EPMC8094622 | biostudies-literature
| S-EPMC5510105 | biostudies-other
| S-EPMC7322134 | biostudies-literature
| S-EPMC6644267 | biostudies-literature
| S-EPMC4289825 | biostudies-other
| S-EPMC4104483 | biostudies-literature
2022-10-14 | PXD035655 | Pride
| S-EPMC3890756 | biostudies-other